U.S. Medical Equipment Stock News

Lantheus Holdings stock barely flinched after earnings, easing just 0.1% and leaving investors to wonder what exactly the market is reacting to. The calm price move sits against a quarter where revenue of about US$388 million met a high bar and earnings per share of roughly US$1.15 kept profit quality squarely in focus. The real tension sits in how investors interpret a solid trailing P/E of 23.9x against a medical imaging specialist that has already banked more than US$275 million of net...

Inogen stock went into this report already under pressure, down over 13% in the past three months. The latest earnings knocked it another 6.8% lower to about US$6 a share. The market is trading this as a setback, yet the headline from the quarter tells a different story. Revenue reached US$95.1m and losses narrowed, with adjusted net income close to breakeven and positive free cash flow. The real flashpoint is the cut to full year revenue guidance. That single move appears to be driving most...

Onto Innovation stock ripped higher today, jumping about 15% after traders digested a Q2 report that focused attention back on the earnings power of its chip tools. The market reaction looks tied to one key message: this quarter was about margins. Onto Innovation reported gross margin of 57% and operating margin of 30%, strong numbers for a semiconductor equipment supplier and central to how investors think about long term cash generation. With management pointing to further margin expansion...

Traders rushed into Unusual Machines, pushing the stock up 7.6% to about $26 after the Q2 print, yet the numbers tell a more complicated story than a simple relief rally. The headline is a very large jump in revenue to about $16.7m while the company still reported a net loss of about $7.8m, or $0.16 per share. The emotional tug of explosive drone demand met the reality of a loss making business that is spending heavily to keep up. The real question for you is whether today’s enthusiasm...

Yelp stock barely flinched after earnings, ticking up about 2% to roughly where it started the week. For a local ads and reviews platform facing a soft ad market, the headline was not the share price. It was a rare mix of pressure and promise as net income for the quarter came in at US$32 million alongside revenue of US$375.5 million. The market’s restrained reaction looks like investors are still processing one key question. Is this profit squeeze a temporary hit from heavier AI and product...

Clean Energy Fuels came into this earnings season with a bruised stock, down almost 30% over the last month, and the latest report hit sentiment again. The share price dropped about 15% to roughly US$1.58 after the Q2 release, even though management called the quarter solid and kept full year adjusted EBITDA guidance at US$70 million to US$75 million. The gap here is not about revenue, which stood at US$106.4 million, or volumes, which grew modestly. The pressure point is profitability...

JFrog stock jumped 7.9% to US$89.61 into the close, which indicates traders responded positively to the headline. The company exceeded the high end of its Q2 2026 guidance and raised full year revenue expectations, supported by software supply chain demand tied to artificial intelligence projects. The short term story is a clean beat and raise. The longer term question is whether fast growing cloud revenue and a 121% net dollar retention rate in the customer base are enough to support a stock...

Ligand Pharmaceuticals stock slipped about 2% after earnings, which might surprise anyone focused on its premium P/E and royalty driven reputation. The headline from this quarter is earnings power. Adjusted diluted earnings per share landed at about US$2.37 on revenue of roughly US$64 million, with royalty revenue doing most of the work. Coming into the print, shares were already up strongly over the past three months. Today’s pullback looks more like a valuation check rather than a verdict...

Eastman Chemical stock has delivered a 25.5% return over the past year, and the current Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares may still trade at a meaningful discount to that level. Over the last 12 months, Eastman Chemical has gained 25.5%, which puts recent shareholders in a stronger position and raises the question of how much upside is left from here. Recent progress on margins and cash generation can support the case for higher intrinsic value, while...

Brighthouse Financial stock has delivered a strong 36.6% return over the past year, yet the broader valuation checks still lean toward the shares looking inexpensive rather than stretched. Over the last 12 months, Brighthouse Financial is up 36.6%, which puts recent share price strength in clear focus for anyone weighing fresh capital. The pending US$4.1b acquisition by an Aquarian Capital affiliate can support the investment case if integration and capital management go smoothly, while the...

Circle Internet Group (NYSE:CRCL) plans to launch its Arc blockchain network on September 16. Arc will go live with founding validators that include BlackRock, DTCC, Mastercard, Visa, and other major financial institutions. The network is designed as a regulated, institutional-grade platform for real-time money movement and financial asset tokenization. This kind of institutional focus on blockchain infrastructure is starting to shape a wider set of opportunities across crypto related...

NerdWallet shares jumped 12.1% to US$9.91 after the Q2 print, a sharp move for a stock that had already been grinding higher over the past week and quarter. The market clearly liked what it saw in the headline numbers, especially the 38% earnings growth over the last year and a P/E of 10x that still sits below the wider US market. Short term traders are reacting to the pop. Long term investors will focus on whether that earnings momentum and a 7.6% trailing net margin justify a price that...

SIGA Technologies just reported a profit and the stock still slipped 2.5% on the day. That gap between price and performance is the real story. Coming into this earnings print, the stock had already fallen over the past week and month, which set expectations low. Then SIGA put up about US$41 million in Q2 revenue and roughly US$0.17 in earnings per share, driven mainly by TPOXX government orders, and closed the quarter with about US$118 million in cash and no debt. The market treated this as...

Peloton Interactive stock inched up 3.1% to US$5.68 after earnings, a modest move for a company that just logged its first full year of positive operating and net income. Traders are reacting to the headline profit. Long term investors are staring at something else entirely. The stock still sits on a 7 day decline of roughly 11% and carries a rich trailing P/E of 39.4x against leisure peers. The real story this quarter is the balance sheet and valuation strain. Profit is now on the table, yet...

CareTrust REIT stock barely moved after earnings, up only 0.2% to US$41.22, yet the results were anything but quiet. The market shrugged. The quarter did not. The real story sits in the cash engine that investors in health care real estate care most about. Normalized funds from operations per share jumped to US$0.51, with normalized funds available for distribution also at US$0.51. Management raised full year guidance for both measures. For a stock that has drifted over the past three months,...

nLIGHT stock just dropped 26% in regular trading, yet the earnings story is more complicated than the price chart suggests. The company posted record Q2 revenue of about US$82.6 million and generated roughly US$20.7 million in operating cash flow, while still reporting a GAAP net loss of US$1.3 million. In the short term, investors are reacting to that loss and a softer Q3 guide. In the longer term, the real debate is whether a rich P/S multiple near 10x and a sizeable loss-making base can be...

BRC Group Holdings stock slipped about 1% today to US$7.18, which is a muted move given the size of the earnings swing investors are processing. The company just posted Q2 net income of US$18.5m with adjusted operating earnings before interest, tax, depreciation and amortisation of US$66m, described as its strongest core operating quarter in nearly three years. Short term traders are still focused on a share price that has fallen over the past three months. Longer term investors are weighing...

Viridian Therapeutics stock climbed about 5% today, yet the headline from this quarter is not a sudden profit swing. The story is a widening loss set against a biotech pipeline that still sits in heavy investment mode. In Q2, Viridian reported basic earnings per share of a loss of US$1.18 and a net loss of about US$127.1 million on revenue of just US$0.3 million. For a development stage biotech this kind of margin squeeze can either be growing pains or a red flag. The following sections...

Currency markets are back in the spotlight after US and Japanese authorities moved to support the yen and rattled global equities. A stronger US dollar can quietly reshape winners and losers, especially for companies with overseas cost bases or import heavy models. This article walks through three stocks from our US Dollar Beneficiaries screener that appear positioned to feel the impact, so you can decide whether they deserve a spot on your watchlist. The stocks covered below are just a...

Serve Robotics stock just dropped 10% today, yet the real shock is not the share price. The reset in full year revenue guidance to US$9 to 10 million, down sharply from US$26 million, is what is driving the sentiment break. A quarterly revenue line of US$3.2 million now sits against a Q2 net loss of US$64 million, which is a wide gap for any growth story. For investors, today is less about robots and more about trust in the economic model. The market is asking whether this guidance reset is a...

National HealthCare stock slipped about 3% today to US$212.72, even though the latest quarter showed profit power that long term holders will likely care more about than a single red day on the screen. Earnings per share in Q2 came in at US$2.58 on revenue of US$408.03m, backing up a trailing net profit margin of 9% and a P/E of 24x that still sits just under healthcare peers. The headline is simple: the price is cooling in the short term while the earnings base and valuation case remain the...

RE/MAX Holdings stock jumped about 5% today, a punchy move for a franchise-heavy real estate brand that has been wrestling with losses. The headline this quarter is simple. The company is still in the red, but the loss narrowed meaningfully compared with the prior quarter, and that is what the market is latching onto. Short term traders are reacting to the bounce. Longer term investors are weighing a different question: Can a business with trailing losses and pressure on interest coverage...

Devon Energy stock has almost doubled investors' money over the past five years, yet the market still prices it on metrics that screen as undervalued and the broader valuation checks lean supportive rather than stretched. Devon Energy has returned 96.5% over five years, which keeps the stock in focus for investors who want to know if the current price still leaves room for attractive risk adjusted returns. The recent merger with Coterra and higher production plans can support expectations...

HCI Group stock came into this earnings season already on a tear, with a 90 day return of about 24%. The market liked what it saw again. Shares jumped another 4.3% to US$188.69 in the first full session after results. The headline is not just another solid quarter. HCI Group delivered Q2 pretax income of more than US$110m and kept its combined ratio near 61%, which is unusually low for a catastrophe exposed insurer. That mix of strong underwriting profitability and growing premium volume is...